A PRELIMINARY STUDY OF RISK FACTORS OF BREAST CANCER AND THE USEFULNESS OF BREAST MRI AS AN ADDITION TO MAMMOGRAPHY IN DETECTING BREAST CANCER IN HIGH RISK WOMEN
DOI:
https://doi.org/10.11113/jt.v78.9867Keywords:
Risk factors, breast cancer, mammography, breast MRI, high risk womenAbstract
The risk factors of breast cancer among women, such as genetic, family history and lifestyle factors, can be divided into high-, intermediate- and average-risk. Determining these risk factors may actually help in preventing breast cancer occurrence. Besides that, screening of breast cancer which include mammography, can be done in promoting early breast cancer detection. Breast magnetic resonance imaging (MRI) has been recommended as a supplemental screening tool in high risk women. The aim of this study was to identify the significant risk factor of breast cancer among women and also to determine the usefulness of breast MRI as an addition to mammography in detection of breast cancer in high risk women. This retrospective cohort study design was conducted using patients’ data taken from those who underwent mammography for screening or diagnostic purposes in Advanced Medical and Dental Institute, Universiti Sains Malaysia, from 2007 until 2015. Data from 289 subjects were successfully retrieved and analysed based on their risk factors of breast cancer. Meanwhile, data from 120 subjects who had high risks and underwent both mammography and breast MRI were further analysed. There were two significant risk factors of breast cancer seen among the study population: family history of breast cancer (p-value=0.012) and previous history of breast or ovarian cancer (p-value <0.001). Breast MRI demonstrated high sensitivity (90%) while mammography demonstrated high specificity (80%) in detection of breast cancer in all 120 subjects. The number of cases of breast cancer detection using breast MRI [46 (38.3%)] was higher compared to mammography [24 (20.0%)]. However, breast MRI was found to be non-significant as an adjunct tool to mammography in detecting breast cancer in high risk women (p-value=0.189). A comprehensive screening guideline and surveillance of women at high risk is indeed useful and should be implemented to increase cancer detection rate at early stageReferences
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D. and Bray, F. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2013. International Agency for Research on Cancer Web site. [Online]. From: http://globocan. iarc. fr [Accessed on 1 December 2015].
Omar, Z. A. and Ibrahim Tamin, N. S. 2011. National Cancer Registry Report, Malaysia Cancer Statistics - Data and Figure 2007, Ministry of Health, Malaysia.
Taib, N. A., Yip, C. H., Ibrahim, M., Ng, C. J. and Farizah, H. 2007. Breast Cancer in Malaysia: Are Our Women Getting The Right Message? 10 Year-Experience in a Single Institution in Malaysia. Asian Pacific Journal of Cancer Prevention. 8(1): 141.
Pathy, N. B., Yip, C. H., Taib, N. A., Hartman, M., Saxena, N., Iau, P., Bulgiba, A. M., Lim, S. E., Lee, S. C., Verkooijen H. M. and Wong, J. E. 2011. Breast Cancer in a Multi-ethnic Asian Setting: Results from the Singapore-Malaysia Hospital-based Breast Cancer Registry. The Breast. 20: S75-80.
Alteri, R., Barnes, C. and Burke, A. American Cancer Society. Breast Cancer Facts and Figures 2013-2014. [Online]. From:
http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. [Accessed on 1 December 2015].
Norsaadah, B., Rusli, B. N., Imran, A. K., Naing, I. and Winn, T. 2005. Risk Factors of Breast Cancer in Women in Kelantan, Malaysia. Singapore Medical Journal. 46(12): 698.
Li, C. I., Malone, K. E. and Daling, J. R. 2003. Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity. Archives of Internal Medicine. 163(1): 49-56.
Oeffinger, K. C., Fontham, E. T., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y. C., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte S. J. and Wolf, A. M. 2015. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society. Jama. 314(15):1599-1614.
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D. and Huynh, P. T. 2013. ACR Appropriateness Criteria Breast Cancer Screening. Journal of the American College of Radiology. 10(1): 11-14.
Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Di Prospero, L. S., Yaffe, M. J., Goel, V., Ramsay, E., Chart, P. L., Cole, D. E. and Taylor, G. A. 2001. Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer. Journal of Clinical Oncology. 19(15): 3524-3531.
Berg, W. A. 2009. Tailored Supplemental Screening for Breast Cancer: What now and what next?. American Journal of Roentgenology. 192(2):390-399.
Kriege, M., Brekelmans, C. T., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M. and Tilanus-Linthorst, M. M. 2004. Efficacy of MRI and Mammography for Breast-cancer Screening in Women with a Familial or Genetic Predisposition. New England Journal of Medicine. 351(5): 427-437.
Collaborative Group on Hormonal Factors in Breast Cancer. 2001. Familial Breast Cancer: Collaborative Reanalysis of Individual Data from 52 Epidemiological Studies including 58 209 Women with Breast Cancer and 101 986 Women without the Disease. The Lancet. 358(9291): 1389-1399.
McPherson, K., Steel, C. M. and Dixon, J. M. 2000. Breast Cancer-Epidemiology, Risk Factors, and Genetics. BMJ. 321(7261): 624-628.
Sifuentes-Ãlvarez, A., Castañeda-MartÃnez, L. Y., Lugo-Nevares, M. and Reyes-Romero, M. A. 2015. Risk Factors associated with Breast Cancer Women's in Durango, Mexico. Ginecol Obstet Mex. 83(11): 662-669.
Singletary, S. E. 2003. Rating the Risk Factors for Breast Cancer. Annals of Surgery. 237(4): 474-482.
Houssami, N., Abraham, L. A., Miglioretti, D. L. et al. 2011. Accuracy and Outcomes of Screening Mammography in Women with a Personal History of Early-stage Breast Cancer. JAMA. 305(8): 790-799.
Buist, D. S. M., Abraham, L. A., Barlow, W. E., Krishnaraj, A., Holdridge, R. C., Sickles, E. A., Carney, A. P., Kerlikowske, K. and Geller, B. M. 2010. For the Breast Cancer Surveillance Consortium. Diagnosis of Second Breast Cancer Events after Initial Diagnosis of Early Stage Breast Cancer. Breast Cancer Research and Treatment. 124(3): 863–873.
Touboul, E., Buffat, L., Belkacémi, Y., Lefranc, J. P., Uzan, S., Lhuillier, P., Faivre, C., Huart, J., Lotz, J. P., Antoine, M. and Pène, F. 1999. Local Recurrences and Distant Metastases after Breast-conserving Surgery and Radiation Therapy for Early Breast Cancer. International Journal of Radiation Oncology* Biology* Physics. 43(1): 25-38.
Borger, J., Kemperman, H., Hart, A., Peterse, H., Van Dongen, J. and Bartelink, H. 1994. Risk Factors in Breast-conservation Therapy. Journal of Clinical Oncology. 12(4): 653-660.
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., Van Tienhoven, G., Andersen, K. W., Sylvester, R. J. and Van Dongen, J. A., 2001. Differences in Risk Factors for Local and Distant Recurrence after Breast-conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials. Journal of Clinical Oncology. 19(6): 1688-1697.
Xie, D., Shu, X. O., Deng, Z., Wen, W. Q., Creek, K. E., Dai, Q., Gao, Y. T., Jin, F. and Zheng, W. 2000. Population-based, Case-control Study of HER2 Genetic Polymorphism and Breast Cancer Risk. Journal of the National Cancer Institute. 92(5): 412-417.
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L. and Hayes, D. F. 2000. Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999. Archives of Pathology and Laboratory Medicine. 124(7): 966-978.
Iqbal, N. and Iqbal N. 2014. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications. Molecular Biology International. 2014 (2014).
Ross, R. K., Paganini-Hill, A., Wan, P. C. and Pike, M. C. 2000. Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen versus Estrogen plus Progestin. Journal of the National Cancer Institute. 92(4): 328-332.
Fioretti, F., Tavani, A., Bosetti, C., La Vecchia, C., Negri, E., Barbone, F., Talamini, R. and Franceschi, S. 1999. Risk Factors for Breast Cancer in Nulliparous Women. British Journal of Cancer. 79(11-12): 1923.
Kenney, L. B., Yasui, Y., Inskip, P. D., Hammond, S., Neglia, J. P., Mertens, A. C., Meadows, A. T., Friedman, D., Robison, L. L. and Diller, L. 2004. Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Annals of Internal Medicine. 141(8): 590-597.
Leach, M. O., Boggis, C., Dixon, A., Easton, D., Eeles, R., Evans, D. and Kessar, P. 2005. Screening with Magnetic Resonance Imaging and Mammography of a UK Population at High Familial Risk of Breast Cancer: A Prospective Multicentre Cohort Study (MARIBS). Lancet. 365(9473): 1769-1778.
Tilanus-Linthorst, M. M., Obdeijn, I. M. M., Bartels, K. C., de Koning, H. J. and Oudkerk, M. 2000. First Experiences in Screening Women at High Risk for Breast Cancer with MR Imaging. Breast Cancer Research and Treatment. 63(1): 53-60.
Lord, S., Lei, W., Craft, P., Cawson, J., Morris, I., Walleser, S. and Houssami, N. 2007. A Systematic Review of the Effectiveness of Magnetic Resonance Imaging (MRI) as an addition to Mammography and Ultrasound in Screening Young Women at High Risk of Breast Cancer. European Journal of Cancer. 43(13): 1905-1917.
Downloads
Published
Issue
Section
License
Copyright of articles that appear in Jurnal Teknologi belongs exclusively to Penerbit Universiti Teknologi Malaysia (Penerbit UTM Press). This copyright covers the rights to reproduce the article, including reprints, electronic reproductions, or any other reproductions of similar nature.
